Tom George Vadaketh - 10 May 2022 Form 3 Insider Report for Bausch Health Companies Inc. (BHC)

Role
EVP, Chief Financial Officer
Signature
Brianna M. Cetrulo, attorney-in-fact for Tom G. Vadaketh
Issuer symbol
BHC
Transactions as of
10 May 2022
Transactions value $
$0
Form type
3
Filing time
12 May 2022, 14:13:03 UTC
Next filing
07 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BHC Common Shares, No Par Value 102K 10 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BHC Non-Qualified Stock Options (right to purchase) 10 May 2022 Common Shares, No Par Value 228K $23.16 Direct F2
holding BHC Non-Qualified Stock Options (right to purchase) 10 May 2022 Common Shares, No Par Value 162K $24.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 101,623 restricted share units ("RSUs") which vest in equal installments on each of the first three anniversaries following the date of grant. Vested RSUs are settled in Common Shares, no par value, of the Issuer.
F2 Vests in equal installments on each of the first three anniversaries of the date of grant.